B lymphocytes: How they develop and function

Blood

Volumn 112, Issue 5, 2008, Pages 1570-1580

  Lebien, Tucker W ^a,c   Tedder, Thomas F ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CELL SELECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LEUKEMIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOLOGY; HISTORY; IMMUNOLOGY; METABOLISM; MOUSE; REVIEW;

B LYMPHOCYTE ANTIGEN;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MEMBRANE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKEMIA; LYMPHOMA; MICE; MODELS, IMMUNOLOGICAL;

EID: 47249099558     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-078071     Document Type: Article

References (109)

1. Cooper MD, Alder MN. The evolution of adaptive immune systems. Cell. 2006;124:815-822.
2. Tiselius A, Kabat EA. Electrophoresis of immune serum. Science. 1938;87:416-417.
3. Fagraeus A. The plasma cellular reaction and its relation to the formation of antibodies in vitro. J Immunol. 1948;58:1-13.
4. Jerne NK. The natural-selection theory of antibody formation. Proc Natl Acad Sci U S A. 1955; 41:849-857.
5. Burnet FM. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci. 1957;20:67-69.
6. Nossal GJ, Lederberg J. Antibody production by single cells. Nature. 1958;181:1419-1420.
7. Nossal GJ. One cell-one antibody: prelude and aftermath. Nat Immunol. 2007;8:1015-1017.
8. Edelman GM, Gaily JA. A model for the 7S antibody molecule. Proc Natl Acad Sci U SA. 1964; 51:846-853.
9. Porter RR. Structure of gamma-globulin and antibodies. Br Med Bull. 1963;19:197-201.
10. Good RA, Zak SJ. Disturbances in gamma globulin synthesis as experiments of nature. Pediatrics. 1956;18:109-149.
11. Cooper MD. Peterson RD, Good RA. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature. 1965;205:143-146.
12. Cooper MD. Raymond DA, Peterson RD, South MA. Good RA. The functions of the thymus system and the bursa system in the chicken. J Exp Med. 1966;123:75-102.
13. Miller JF, Mitchell GF Cell to cell interaction in the immune response, I: hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med. 1968;128:801-820.
14. Mitchell GF, Miller JF. Cell to cell interaction in the immune response, II: the source of hemolysinforming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J ExpMed. 1968;128:821-837.
15. Coombs RR, Feinstein A, Wilson AB. Immunoglobulin determinants on the surface of human lymphocytes. Lancet. 1969:2:1157-1160.
16. Froland S, Natvig JB, Berdal P. Surface-bound immunoglobulin as a marker of B lymphocytes in man. Nat New Biol. 1971;234:251-252.
17. Raff MC. T and B lymphocytes and immune responses. Nature. 1973;242:19-23.
18. Greaves MR Owen JJT, Raff MC.T and B lymphocytes: Origins. Properties, and Roles in Immune Responses. Amsterdam, The Netherlands: Excerpta Medica; 1974.
19. Preud'homme JL, Seligmann M. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood. 1972;40:777-794.
20. Raff MC, Megson M, Qwen JJ, Cooper MD. Early production of intracellular IgM by B-lymphocyte precursors in mouse. Nature. 1976;259:224-226.
21. Gathings WE, Lawton AR, Cooper MD. Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol. 1977;7:804-810.
22. Vogler LB. Crist WM, Bockman DE, Pearl ER, Lawton AR, Cooper MD. Pre-B-cell leukemia: a new phenotype of childhood lymphoblastic leukemia. N Engl J Med. 1978;298:872-878.
23. LeBienTW, Hozier J, Minowada J, Kersey JH. Origin of chronic myelocytic leukemia in a precursor of pre-B lymphocytes. N Engl J Med. 1979; 301:144-147.
24. Hardy RR, Kincade PW, Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity. 2007;26:703-714.
25. LeBien TW. Fates of human B-cell precursors. Blood. 2000;96:9-23.
26. Brack C, HiramaM, Lenhard-Schuller R, Tonegawa S. A complete immunoglobulin gene is created by somatic recombination. Cell. 1978;15: 1-14.
27. Reynaud CA. Bertocci B, Dahan A, Weill JC. Formation of the chicken B-cell repertoire: ontogenesis, regulation of Ig gene rearrangement, and diversification by gene conversion. Adv Immunol. 1994;57:353-378.
28. Becker RS, Knight KL. Somatic diversification of immunoglobulin heavy chain VDJ genes: evidence for somatic gene conversion in rabbits. Cell. 1990;63:987-997.
29. Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 1989;59:1035-1048.
30. Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 1990;248:1517-1523.
31. Alt FW, Blackwell TK, DePinho RA, Reth MG, Yancopoulos GD. Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev. 1986;89:5-30.
32. Sakaguchi N, Melchers F. Lambda 5, a new lightchain-related locus selectively expressed in pre-B lymphocytes. Nature. 1986;324:579-582.
33. Melchers F. The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat Rev Immunol. 2005;5:578-584.
34. Bradl H, Wittmann J, Milius D, Vettermann C, Jack HM. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cellassociated heparan sulfate. J Immunol. 2003; 171:2338-2348.
35. Gauthier L, Rossi B, Roux F, Termine E, Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A. 2002;99: 13014-13019.
36. Bankovich AJ, Raunser S, Juo ZS, WalzT, Davis MM, Garcia KC. Structural insight into pre-B cell receptor function. Science. 2007;316:291-294.
37. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 1997;90:1073-1083.
38. Kincade PW, Lawton AR, Bockman DE, Cooper MD. Suppression of immunoglobulin G synthesis as a result of antibody-mediated suppression of immunoglobulin M synthesis in chickens. Proc Natl Acad Sci U S A. 1970;67:1918-1925.
39. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNAediting enzyme. Cell. 2000;102:553-563.
40. HonjoT, Nagaoka H, Shinkura R, Muramatsu M. AID to overcome the limitations of genomic information. Nat Immunol. 2005;6:655-661.
41. Reynaud CA, Aoufouchi S, Faili A, Weill JC. What role for AID: mutator, or assembler of the immunoglobulin mutasome? Nat Immunol. 2003;4:631-638.
42. Okazaki IM, Kotani A, Honjo T. Role of AID in tumorigenesis. Adv Immunol. 2007;94:245-273.
43. Milne CD, Paige CJ. IL-7: a key regulator of B lymphopoiesis. Semin Immunol. 2006;18:20-30.
44. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004; 22:625-655.
45. Nutt SL, Kee BL. The transcriptional regulation of Bcell lineage commitment. Immunity. 2007;26: 715-725.
46. Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol. 2007;8:463-470.
47. Nutt SL, Heavey B, Relink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999; 401:556-562.
48. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007; 449:473-477.
49. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446:758-764.
50. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495-497.
51. Stashenko P, Nadler LM, Hardy R, Schlossman SF Characterization of a human B lymphocytespecific antigen. J Immunol. 1980;125:1678-1685.
52. Campbell KS, Hager EJ, Friedrich RJ, Cambier JC. IgM antigen receptor complex contains phosphoprotein products of B29 and mb-1 genes. Proc Natl Acad Sci U S A. 1991;88:3982-3986.
53. Reth M. Antigen receptor tail clue. Nature. 1989; 338:383-384.
54. Messina JP, Gilkeson GS, Pisetsky DS. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 1991;147:1759-1764.
55. Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol. 2003;24:343-349.
56. CoutinhoA, Moller G. Thymus-independent B-cell induction and paralysis. Adv Immunol. 1975;21: 113-236.
57. Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature. 1991;354:389-392.
58. Kelsoe G. Life and death in germinal centers (redux). Immunity. 1996;4:107-111.
59. Allen CD, OkadaT, Cyster JG. Germinal-center organization and cellular dynamics. Immunity. 2007;27:190-202.
60. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. The "Ly-1 B" cell subpopulation in normal immunodefective. and autoimmune mice. J Exp Med. 1983;157:202-218.
61. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595-621.
62. Dorshkind K, Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol. 2007;7:213-219.
63. Montecino-Rodriguez E, Leathers H. Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol. 2006;7:293-301.
64. Haas KM, PoeJC, Steeber DA, Tedder TF. B-1a and B-1 b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 2005;23:7-18.
65. Pillai S, Cariappa A, Moran ST. Marginal zone B cells. Annu Rev Immunol. 2005;23:161-196.
66. Steiniger B, Timphus EM, Barth PJ. The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants. Histochem Cell Biol. 2006;126:641-648.
67. Radbruch A, Muehlinghaus G, Luger EO, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006;6:741-750.
68. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol. 2005;23:487-513.
69. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol. 2005;5:230-242.
70. Dilillo DJ, Hamaguchi Y, UedaY, et al. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol. 2008;180:361-371.
71. Ron Y, De Baetselier P, Gordon J, Feldman M, Segal S. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur J Immunol. 1981;11:964-968.
72. Ron Y, Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol. 1987;138:2848-2856.
73. Janeway CA, Ron J Jr, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol. 1987;138:1051-1055.
74. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985;314:537-539.
75. Bouaziz JD, Yanaba K, Venturi GM, et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ cell activation in mice. Proc Natl Acad Sci U S A. 2007;104:20882-20887.
76. Harris DP, Haynes L, Sayles PC, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1:475-482.
77. Mizoguchi A, Bhan AK. Acasefor regulatory B cells. J Immunol. 2006;176:705-710.
78. Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF.A regulatory B cell subset with a unique phenotype controls T cell-dependent inflammatory responses. Immunity. In press.
79. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the sre family of protein-tyrosine kinases. Nature. 1993;361:226-233.
80. Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72:279-290.
81. Bruton OG. Agammaglobulinemia. Pediatrics. 1952;9:722-728.
82. Conley ME, Broides A, Hernandez-Trujillo V, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216-234.
83. Rawlings DJ. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin Immunol. 1999; 91:243-253.
84. Valiaho J, Smith CI, Vihinen M. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat. 2006;27:1209-1217.
85. Casanova JL Abel L. Primary immunodeficiencies: afield in its infancy. Science. 2007;317:617-619.
86. Bacchelli G, Buckridge S, Thrasher AJ, Gaspar HB. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol. 2007;149: 401-409.
87. Durandy A, Taubenheim N, Peron S. Fischer A. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv Immunol. 2007;94:275-306.
88. Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (Al D) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 2000;102:565-575.
89. Goodnow CC, Adelstein S, Basten A. The need for central and peripheral tolerance in the B cell repertoire. Science. 1990;248:1373-1379.
90. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol. 2001;2:764-766.
91. Lange K, Gold MM, Weiner D, Simon V. Autoantibodies in human glomerulonephritis. J Glin Invest. 1949;28:50-55.
92. Franklin EC, Holman HR, Muller-Eberhard HJ, Kunkel HG. An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med. 1957; 105:425-438.
93. Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity. 2008;28: 18-28.
94. McDonnell TJ, Deane N, Piatt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989;57:79-88.
95. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol. 1991;9:243-269.
96. Drappa J, VaishnawAK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med. 1996;335:1643-1649.
97. Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol. 2006;6:394-403.
98. Uchida J, Hamaguchi Y, Oliver JA, et al. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med. 2004;199:1659-1669.
99. Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285:260-263.
100. Mackay F Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2:465-475.
101. Poe JC, Fujimoto Y, Hasegawa M, et al. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol. 2004;5:1078-1087.
102. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111:3941-3967.
103. Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol. 2005;87:163-208.
104. Korsmeyer SJ, Arnold A, Bakhshi A, et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983;71:301-313.
105. TsujimotoY, Finger LR, Yunis J, Nowell PC, Croce GM. Gloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1097-1099.
106. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, Bcl-6, in diffuse largecell lymphoma. Science. 1993;262:747-750.
107. Kuppers R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A. 1994;91: 10962-10966.
108. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316:604-608.
109. Vigorito E, Perks KL, Abreu-Goodger C, et al. mi-croRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007:27:847-859. Copyright 2007 by The American Society of Hematology; all rights reserved.